Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) Shares Outstanding (Diluted Average) (2023 - 2025)

Historic Shares Outstanding (Diluted Average) for Lexaria Bioscience (LEXX) over the last 7 years, with Q4 2025 value amounting to $21.4 million.

  • Lexaria Bioscience's Shares Outstanding (Diluted Average) rose 2824.2% to $21.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was $21.4 million, marking a year-over-year increase of 2824.2%. This contributed to the annual value of $18.0 million for FY2025, which is 4533.88% up from last year.
  • Latest data reveals that Lexaria Bioscience reported Shares Outstanding (Diluted Average) of $21.4 million as of Q4 2025, which was up 2824.2% from $18.0 million recorded in Q3 2025.
  • In the past 5 years, Lexaria Bioscience's Shares Outstanding (Diluted Average) ranged from a high of $21.4 million in Q4 2025 and a low of $6.6 million during Q3 2023
  • Over the past 3 years, Lexaria Bioscience's median Shares Outstanding (Diluted Average) value was $15.3 million (recorded in 2024), while the average stood at $14.5 million.
  • In the last 5 years, Lexaria Bioscience's Shares Outstanding (Diluted Average) surged by 8723.69% in 2024 and then surged by 2824.2% in 2025.
  • Lexaria Bioscience's Shares Outstanding (Diluted Average) (Quarter) stood at $9.1 million in 2023, then soared by 84.15% to $16.7 million in 2024, then rose by 28.24% to $21.4 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $21.4 million in Q4 2025, compared to $18.0 million in Q3 2025 and $18.3 million in Q2 2025.